Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

← Back to all medicines

Adrenaline (Epinephrine) 1mg/ml (1:1000) solution for injection (ampoule)

⚠ This medicine appears to have been discontinued

The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.

If you were prescribed this medicine, other products containing Adrenaline acid tartrate may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.

Active substance: Adrenaline acid tartrate
Source: electronic medicines compendium (emc)
Official leaflet: Read the PIL on emc

What it is and what it is used for

for Adrenaline (Epinephrine) belongs to a class of drugs called sympathomimetic agents. Adrenaline injection can be used for the emergency treatment of severe allergic reactions.

2. What you need to know before Adrenaline Injection is Given You should not be given Adrenaline Injection if you are:

  • allergic to adrenaline, or to any of the other ingredients of this medicine (listed in section 6)
  • Adrenaline injection should not be used in areas such as fingers, toes, ears, nose, genitalia or buttocks, as the blood supply to these areas might become inadequate. Warnings and precautions Talk to your doctor or pharmacist or nurse before using Adrenaline Injection if:
  • you are elderly
  • you suffer from any heart problem, particularly if it affects the heart rate or if you suffer from chest pain
  • you have problems with your brain e.g. stroke, brain damage or blood vessel disease
  • you have an overactive thyroid, diabetes or glaucoma (high pressure in the eye)
  • you have phaeochromocytoma (a tumour on the adrenal gland)
  • you have low blood levels of potassium or high blood levels of calcium
  • you have a tumour on your prostate gland or kidney disease
  • you are in shock or have lost a lot of blood
  • you are going to have a surgery under general anaesthesia
  • you are suffering from high blood pressure
  • you have atherosclerosis which is a narrowing and hardening of the body's blood vessels (your doctor will advise you). If any of the above apply to you or your child please tell your doctor before you are given this medicine. Other medicines and Adrenaline Injection Tell your doctor or nurse if you are taking or have recently taken or might take any other medicines, including medicines obtained without a prescription. A large number of drugs can interact with Adrenaline Injection which can significantly alter their effects. These drugs include:
  • monoamine oxidase inhibitors (MAOI) or tricyclic antidepressants such as imipramine, amitriptyline, both used for depression
  • cardiac glycosides such as digoxin, used for heart failure
  • guanethidine, used for the rapid control of blood pressure
  • diuretics ("water tablets") such as hydrochlorothiazide, furosemide
  • inhaled general anaesthetics, such as halothane
  • medicines to raise or lower your blood pressure including betablockers, e.g. propranolol, atenolol, bisoprolol, phentolamine
  • anti-diabetic drugs like insulin or oral hypoglycaemic agents (e.g. glipizide)
  • aminophylline and theophylline (medicines to help you breathe)
  • corticosteroids (medicines used to treat inflammatory conditions in your body such as asthma or arthritis)
  • antihistamines (for example: diphenhydramine), used for the treatment of allergies
  • medicines used to treat mental illness like chlorpromazine, pericyazine or fluphenazine
  • medicines used to treat an underactive thyroid gland
  • oxytocin (used to induce labour at term and to control bleeding after delivery)
  • any cough or cold remedies (sympathomimetics). If you are already taking one of these medicines, speak to your doctor before you receive Adrenaline Injection. Pregnancy and breast-feeding: If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. Adrenaline should only be used during pregnancy and

Adrenaline Injection contains sodium metabisulphite This medicine contains Sodium Metabisulphite which may cause allergic (hypersensitive) type reactions in some people, which can lead to breathing difficulties or collapse. People with a history of asthma or allergies (hypersensitivity) are most likely to experience these problems.

How to take it

Your doctor will give Adrenaline Injection to you into a muscle (Intramuscular – IM), however, in emergencies your doctor may give you a diluted injection into your vein (intravenous – IV). Adrenaline injection must NOT be given in areas such as fingers, toes, ears, nose, genitalia or buttocks , as the blood supply to these areas might become inadequate. If repeated injections are required your doctor will change the site of injection. It will be administered by a trained healthcare professional. Your doctor will decide the most suitable dosage and route of administration for your particular case according to your age and physical circumstances. Adults The usual dose is 0.5ml. If necessary, this dose may be repeated several times at 5-minute intervals. Elderly There are no specific dose regimens for adrenaline injection in elderly patients, however adrenaline should be used with great caution. Children The following doses of Adrenaline Solution for Injection are recommended: Age

Dose

Over 12 years

0.5 mg IM (0.5ml 1mg/ml solution) 0.3 mg IM (0.3ml 1mg/ml solution) if the child is small or pre-pubertal)

6 – 12 years

0.3 mg IM (0.3ml 1mg/ml solution)

6 months – 6 years

0.15 mg IM (0.15ml 1mg/ml solution)

Under 6 months

0.01mg/kg IM (0.01ml/kg 1mg/ ml solution)

If necessary, these doses may be repeated several times at 5 – 15 minutes intervals according to blood pressure, pulse and respiratory function. A small volume syringe should be used. If you think you have been given more Adrenaline Injection more than you should. As this medicine will be given to you whilst you are in hospital, it is unlikely that you will be given too little

5016-D

100mm Measurement Verification Bar

The following information is for healthcare professionals only:

Preparation and handling Do not use Adrenaline (Epinephrine) 1 mg/ml (1:1000) Solution for Injection if you notice that it is discoloured. Repeated local administration may cause necrosis at the injection site. The best site for intramuscular injection is anterolateral in the middle third of the thigh. Needle used for the injection must be long enough to ensure that the adrenaline reaches the muscle. Intramuscular injection in fingers, toes, ears, nose genitalia or buttocks should be avoided due to the risk of tissue necrosis. Prolonged administration may cause metabolic acidosis, renal necrosis or tachyphylaxis. Use of adrenaline injection should be avoided or done with the greatest caution in patients under general anesthesia with halothane or other halogenated anesthetics, due to the risk of developing ventricular fibrillation. Do not mix with other medicines unless compatibility has been confirmed. Adrenaline injection should not be used during the second stage of labour. Accidental intravascular injection may result in cerebral hemorrhage due to the sudden blood pressure rise. Begin monitoring the patient as soon as possible (heart rate, blood pressure, ECG, pulse oximetry) to assess the response to adrenaline. Incompatibilities Adrenaline/epinephrine is rapidly denatured by oxidising agents and alkalis including sodium bicarbonate, halogens, nitrates, nitrites, and salts of iron, copper and zinc. Dosage and method of administration Adrenaline (Epinephrine) 1 mg/ml (1:1000) Solution for Injection is intended for intramuscular use. Do not give Adrenaline (Epinephrine) 1 mg/ml (1:1000) Solution for Injection intravenously. Intravenous administration of adrenaline for anaphylaxis requires the use of a 0.1mg/ml (1:10000) adrenaline solution. The IM route is generally preferred in the initial treatment of anaphylaxis, the IV route is generally more appropriate in the Intensive Care Unit or Emergency Department setting. Adrenaline (Epinephrine) 1mg/ml (1:1000) solution for injection is not suitable for IV use. If the adrenaline 0.1 mg/ml (1:10000) injection is not available, Adrenaline (Epinephrine) 1mg/ml (1:1000) solution must be diluted to 0.1 mg/mL (1:10000) before IV use. The IV route for injection of adrenaline must be used with extreme caution and is best reserved for specialists familiar with IV use of adrenaline. Acute anaphylaxis Intramuscular route of administration is preferred for most individuals in need of treatment adrenaline to acute anaphylaxis. Continued overleaf

For adults, the usual dose is 0.5 mg (0.5ml of Adrenaline 1mg/ml (1:1000)). If necessary, this dose may be repeated several times at 5-minute intervals according to blood pressure, pulse and respiratory function. Elderly: There are no specific dosage regimes for adrenaline injection in elderly patients. However, Adrenaline should be used with great caution in these patients who may be more susceptible to the cardiovascular side effects of adrenaline. Paediatric population The following doses of Adrenaline (Epinephrine) 1mg/ml (1:1000) Injection are recommended: Age Dose Over 12 years 0.5 mg IM (0.5ml 1mg/ml (1:1000 ) solution) 0.3 mg IM (0.3ml 1mg/ml (1:1000) solution) if the child is small or pre-pubertal) 6 – 12 years 0.3 mg IM (0.3ml 1mg/ml (1:1000) solution) 6 months – 6 years 0.15 mg IM (0.15ml 1mg/ml (1:1000) solution) Under 6 months 0.01mg/kg IM (0.01ml/kg 1mg/ml (1:1000) solution) If necessary, these doses may be repeated several times at 5 – 15 minutes intervals according to blood pressure, pulse and respiratory function. A small volume syringe should be used. Disposing Non-used drugs and waste should be disposed of in accordance with local requirements. Overdose Sign Adrenaline overdose leads to severe hypertension. Cerebral, cardiac or vascular accidents which could be potentially fatal may occur as a result (cerebral haemorrhage, dysrhythmias such as transient bradycardia followed by tachycardia that may result in arrhythmia, myocardial necrosis, acute pulmonary oedema, renal insufficiency). Treatment The effects of adrenaline may be counteracted, depending on the condition of the patient, by administration of quick-acting vasodilators, of quickacting alpha-adrenoreceptor blocking agents (e.g. phentolamine), or beta-adrenoreceptor blocking agents (e.g. propranolol). However, due to the short half-life of adrenaline, treatment with these medicines may not be necessary. In case of prolonged hypotensive reaction, administration of another vasopressive agent such as noradrenaline may be required.

or too much, however, tell your doctor or nurse if you have any concerns.

Possible side effects

Like all medicines Adrenaline Injection can cause side effects, although not everybody gets them. If you experience any of these following side effects, stop using this medicine and report to a doctor immediately:

  • allergic reactions although serious allergic reactions are rare
  • any sudden wheeziness, difficulty in breathing, swelling of the eyelids, face or lips, rash or itching (especially affecting your whole body). Other side effects (Not known: frequency cannot be estimated from the available data):
  • headache
  • dizziness
  • feelings of anxiety or fear or restlessness
  • trembling
  • insomnia, confusion, irritability
  • abnormal mood or behaviour
  • a dry mouth or producing too much saliva
  • weakness or sweating
  • changes in the rhythm and speed of the heart
  • palpitation (fast or irregular heartbeat), tachycardia (abnormally fast resting heart rate), angina (chest pain with varying intensity)
  • high blood pressure
  • coldness of the arms or legs
  • breathlessness
  • reduced appetite, feeling sick or being sick
  • repeated injections may damage tissues at the site of the injection,
  • difficulty of not being able to pass water
  • metabolic acidosis (an imbalance of certain constituents in your blood) may occur
  • bleeding in the head
  • paralysis of one half of the body
  • increased sugar levels in the blood
  • breakdown of fat in the body
  • decreased blood potassium levels
  • pulmonary oedema
  • chest pain (acute angina)
  • heart attack (acute myocardial infarction)
  • Pale appearance (Pallor)
  • Passing out (syncope)
  • dilation of the pupil (mydriasis) In patients with Parkinson's disease Adrenaline (Epinephrine) may increase rigidity (stiffness) and tremors (shaking). After being given this product, you may experience slight pain, minor bruising/bleeding or some left over liquid in the place where you have been injected

effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine

This medicinal product is authorised in the Member States of the EEA under the following names: UK

Adrenaline (Epinephrine) 1 mg/ml (1:1000) solution for Injection

How to store it

Adrenaline Injection

FR

Adrenaline Ethypharm 1 mg/ml (1:1000) solution for injection

ES

Adrenalina Ethypharm 1 mg/ml (1:1000) solución inyectable

FI

Adrenalin Ethypharm

DE

Adrenaline Ethypharm 1 mg/ml (1:1000) solution for injection

DK

Adrenalin Ethypharm 1 mg/ml (1:1000) solution for injection

IT

Adrenalina Ethypharm

NO

Adrenalin Ethypharm

SE

Adrenalin Ethypharm 1 mg/ml (1:1000) solution for injection

Keep all medicines out of the sight and reach of children. Your doctor, nurse or paramedic will check that the expiry date on the label has not been passed before administering Adrenaline Injection to you. The expiry date refers to the last day of the month. You should not be given the Adrenaline Injection if you notice it has been used or shows signs of visible damage. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

Contents of the pack and other information

What Adrenaline Injection contains The active ingredient is Adrenaline (Epinephrine) (as acid tartrate) 1mg per ml. This medicinal product contains less than 1mmol sodium (23mg) per dose as Sodium Chloride (essentially 'sodium-free'). The other ingredients are Sodium Metabisulphite and Water for Injections. Hydrochloric acid and sodium hydroxide may be added to adjust the acidity. What Adrenaline Injection looks like and contents of the pack The Adrenaline Injection is a clear, colourless solution supplied in a pack of 10 glass ampoules each containing 0.5, 1, 2, 5 or 10ml. Marketing Authorisation Holder and Manufacturer: Macarthys Laboratories Limited Bampton Road, Harold Hill, Romford, Essex, RM3 8UG

Product licence number: PL 01883/6118R This leaflet was last revised in: 09/2019

Reporting of side effects If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side

D05016

5016-D

100mm Measurement Verification Bar

Frequently asked questions about Adrenaline (Epinephrine) 1mg/ml (1:1000) solution for injection (ampoule)

How do I take Adrenaline (Epinephrine) 1mg/ml (1:1000) solution for injection (ampoule)?

Adrenaline (Epinephrine) 1mg/ml (1:1000) solution for injection (ampoule) comes as injection containing 1mg/ml. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.

What is the active substance in Adrenaline (Epinephrine) 1mg/ml (1:1000) solution for injection (ampoule)?

The active substance in Adrenaline (Epinephrine) 1mg/ml (1:1000) solution for injection (ampoule) is adrenaline acid tartrate.

Where does this information come from?

This leaflet reproduces the patient information leaflet approved for Adrenaline (Epinephrine) 1mg/ml (1:1000) solution for injection (ampoule), as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.

Can I get Adrenaline (Epinephrine) 1mg/ml (1:1000) solution for injection (ampoule) without a prescription?

Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.

About this leaflet

The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.

Medical disclaimer: This page is for information only and does not replace advice from your doctor or pharmacist. Always read the leaflet supplied with your medicine. If you are unwell, call NHS 111; in an emergency, call 999.

Medicines with the same active substance: Adrenaline acid tartrate (10 medicines)
See every medicine containing this substance, or browse the full A–Z of active substances.
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
Technical information intended for healthcare professionals (doctors and pharmacists). The Summary of Product Characteristics (SmPC) is the official document approved by the MHRA/EMA. It does not replace the patient leaflet or a doctor’s advice.

4.1. Therapeutic indications

Adrenaline (Epinephrine) 1 mg/ml (1:1000) Solution for Injection may be used in the emergency treatment of

• anaphylaxis

• acute allergic reactions

4.2. Posology and method of administration

This medicinal product will be administered by a trained healthcare professional.

The intramuscular (IM) route is recommended by the EU Resuscitation Council as the most appropriate for most individuals who have to give adrenaline to treat an anaphylactic reaction. The patient should be monitored as soon as possible (pulse, blood pressure, ECG, pulse oximetry). This will help monitor the response to adrenaline.

The best site for IM injection is the anterolateral aspect of the middle third of the thigh.

The needle used for injection needs to be sufficiently long to ensure that the adrenaline is injected into muscle.

The subcutaneous route for adrenaline is not recommended for treatment of an anaphylactic reaction as it is less effective.

Adults:

The usual dose is 0.5 mg (0.5ml of adrenaline 1mg/ml (1:1000)). If necessary, this dose may be repeated several times at 5-minute intervals according to blood pressure, pulse and respiratory function.

Elderly:

There are no specific dosage regimes for adrenaline injection in elderly patients. However, Adrenaline should be used with great caution in these patients who may be more susceptible to the cardiovascular side effects of adrenaline.

Paediatric population

The following doses of Adrenaline (Epinephrine) 1 mg/ml (1:1000) Solution for Injection are recommended:

Age

Dose

Over 12 years

0.5 mg IM (0.5ml 1mg/ml (1:1000) solution)

0.3 mg IM (0.3ml 1mg/ml (1:1000) solution) if the child is small or pre-pubertal)

6 - 12 years

0.3 mg IM (0.3ml 1mg/ml (1:1000) solution)

6 months - 6 years

0.15 mg IM (0.15ml 1mg/ml (1:1000) solution)

Under 6 months

0.01mg/kg IM (0.01ml/kg 1mg/ml (1:1000) solution)

If necessary, these doses may be repeated several times at 5 - 15 minutes intervals according to blood pressure, pulse and respiratory function.

A small volume syringe should be used.

Do not give Adrenaline (Epinephrine) 1mg/ml (1:1000) solution for injection intravenously.

Intravenous administration of adrenaline for anaphylaxis requires the use of a 1:10,000 adrenaline solution (please refer section 4.4 for intravenous use).

4.3. Contraindications

Hypersensitivity to the active substance or to any of the excipients listed in section 6.1

Contraindications are relative as this product is intended for use in life-threatening emergencies.

• Use in fingers, toes, ears, nose genitalia or buttocks owing to the risk of ischaemic tissue necrosis.

• Do not use if solution is discoloured.

4.4. Special warnings and precautions for use

This product is for emergency use only and medical supervision of the patients is necessary after administration.

Adrenaline (Epinephrine) 1 mg/ml (1:1000) Solution for Injection 1mg/ml (1:1000) is not suitable for IV use.

The IM route is generally preferred in the initial treatment of anaphylaxis, the IV route is generally more appropriate in the Intensive Care Unit or Emergency Department setting. Adrenaline (Epinephrine) 1mg/ml (1:1000) solution for injection is not suitable for IV use. If the adrenaline 0.1 mg/ml (1:10000) injection is not available, Adrenaline 1mg/ml (1:1000) solution must be diluted to 0.1 mg/mL (1:10000) before IV use. The IV route for injection of adrenaline must be used with extreme caution and is best reserved for specialists familiar with IV use of adrenaline.

Adrenaline should be used with caution in patients with hyperthyroidism, diabetes mellitus, narrow angle glaucoma, phaeochromocytoma, hypertension, hypokalaemia, hypercalcaemia, severe renal impairment, prostatic adenoma leading to residual urine, cerebrovascular disease, elderly patients, patients with shock (other than anaphylactic shock), organic heart disease or cardiac dilatation, (severe angina pectoris, obstructive cardiomyopathy, hypertension), as well as most patients with arrhythmias, organic brain damage or cerebral arteriosclerosis. Anginal pain may be induced when coronary insufficiency is present.

Adrenaline should be used with caution during the second stage of labour (See Pregnancy and Lactation).

Adrenaline may cause or exacerbate hyperglycaemia, blood glucose should be monitored, particularly in diabetic patients.

Repeated local administration may produce necrosis at the sites of injection.

Prolonged administration may induce metabolic acidosis, renal necrosis and tachyphylaxis.

Adrenaline should be avoided or used with extreme caution in patients undergoing anaesthesia with halothane or other halogenated anaesthetics, in view of the risk of inducing ventricular fibrillation.

Accidental intravascular injection may result in cerebral haemorrhage due to the sudden rise in blood pressure.

Monitor the patient as soon as possible (pulse, blood pressure, ECG, pulse oximetry) in order to assess the response to adrenaline.

The best site for IM injection is the anterolateral aspect of the middle third of the thigh. The needle used for injection needs to be sufficiently long to ensure that the adrenaline is injected into muscle. .

Adrenaline Injection contains sodium metabisulfite that can cause allergic-type reactions, including anaphylaxis and life-threatening or less severe asthmatic episodes, in certain susceptible individuals.

The presence of sodium metabisulfite in parenteral Adrenaline and the possibility of allergic-type reactions should not deter use of the drug when indicated for the treatment of serious allergic reactions or for other emergency situations.

4.5. Interaction with other medicinal products and other forms of interaction

Sympathomimetic agents/Oxytocin: Adrenaline should not be administered concomitantly with oxytocin or other sympathomimetic agents because of the possibility of additive effects and increased toxicity.

Alpha-adrenergic blocking agents:

Alpha-blockers such as phentolamine antagonise the vasoconstriction and hypertension effects of adrenaline.

Beta-adrenergic blocking agents:

Severe hypertension and reflex bradycardia may occur with non-selective beta- blocking drugs such as propranolol, due to alpha-mediated vasoconstriction.

Beta-blockers, especially non-cardioselective agents, also antagonise the cardiac and bronchodilator effects of adrenaline. Patients with severe anaphylaxis who are taking non-cardioselective beta-blockers may not respond to adrenaline treatment.

General anaesthetics

Administration of adrenaline in patients receiving halogenated hydrocarbon general anaesthetics that increase cardiac irritability and seem to sensitise the myocardium to adrenaline may result in arrhythmias including ventricular premature contractions, tachycardia, or fibrillation (See section 4.4).

Antidepressant agents:

Tricyclic antidepressants such as imipramine may potentiate the effects of adrenaline, especially on heart rhythm and rate.

Non-selective MAO inhibitors:

increased pressor action of adrenaline, usually moderate.

Selective MAO-A inhibitors, Linezolid (by extrapolation from non-selective MAO inhibitors): Risk of aggravation of pressor action.

Antihypertensive agents:

Adrenaline specifically reverses the antihypertensive effects of adrenergic neurone blockers such as guanethidine, with the risk of severe hypertension. Adrenaline increases blood pressure and may antagonise the effects of antihypertensive drugs.

Phenothiazines:

Adrenaline should not be used to counteract circulatory collapse or hypotension caused by phenothiazines: a reversal of adrenaline's pressor effects resulting in further lowering of blood pressure may occur.

Other medicinal products:

Adrenaline should not be used in patients receiving high dosage of other drugs (e.g. cardiac glycosides) that can sensitise the heart to arrhythmias. Some antihistamines (e.g. diphenhydramine) and thyroid hormones may potentiate the effects of Adrenaline, especially on heart rhythm and rate.

Hypokalaemia:

The hypokalaemic effect of adrenaline may be potentiated by other drugs that cause potassium loss, including corticosteroids, potassium-depleting diuretics, aminophylline and theophylline.

Hyperglycaemia:

Adrenaline-induced hyperglycaemia may lead to loss of blood-sugar control in diabetic patients treated with insulin or oral hypoglycaemic agents.

4.6. Fertility, pregnancy and lactation

Pregnancy

A teratogenic effect has been demonstrated in animal studies.

Adrenaline crosses the placenta. There is some evidence of a slightly increased incidence of congenital abnormalities. Injection of adrenaline may cause anoxia, fetal tachycardia, cardiac irregularities, extra systoles and louder heart sounds. Adrenaline usually inhibits spontaneous or oxytocin induced contractions of the uterus and may delay the second stage of labour. In dosage sufficient to reduce uterine contractions, the drug may cause a prolonged period of uterine atony with haemorrhage. For this reason, parenteral adrenaline should not be used during the second stage of labour.

Adrenaline should only be used during pregnancy if the potential benefits outweigh the possible risks to the fetus.

Breast-feeding

Adrenaline is distributed into breast milk. Breast-feeding should be avoided in mothers receiving adrenaline injection.

Fertility

No data are available with respect to the impact of adrenaline on fertility.

4.7. Effects on ability to drive and use machines

Not applicable in normal conditions of use

4.8. Undesirable effects

The adverse events of adrenaline mainly relate to the stimulation of both alpha- and beta-adrenergic receptors. The occurrence of undesirable effects depends on the sensitivity of the individual patient and the dose involved.

Metabolism and nutrition disorders:

Frequency not known: hyperglycaemia, hypokalaemia, metabolic acidosis.

Psychiatric disorders:

Frequency not known: anxiety, nervousness, fear, hallucinations.

Nervous system disorders:

Frequency not known: headache, tremors, dizziness, syncope.

In patients with Parkinsonian Syndrome, Adrenaline increases rigidity and tremor.

Eye disorders:

Frequency not known: mydriasis.

Cardiac disorders:

Frequency not known: palpitations, tachycardia. In high dosage or for patients sensitive to adrenaline: cardiac dysrhythmia (sinus tachycardia, ventricular fibrillation/cardiac arrest), acute angina attacks, and risk of acute myocardial infarction.

Vascular disorders:

Frequency not known: pallor, coldness of the extremities. In high dosage or for patients sensitive to adrenaline: hypertension (with risk of cerebral haemorrhage), vasoconstriction (for example cutaneous, in the extremities or kidneys)

Respiratory, thoracic and mediastinal disorders:

Frequency not known: dyspnoea.

Gastrointestinal disorders:

Frequency not known: nausea, vomiting.

General disorders and administration site conditions:

Frequency not known: sweating, weakness

Repeated local injections may produce necrosis at sites of injection as a result of vascular constriction.

Reporting of suspected adverse reactions

Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

4.9. Overdose

Over dosage or inadvertent intravenous administration of adrenaline may produce severe hypertension. Cerebral, cardiac or vascular accidents which could be potentially fatal may occur as a result (cerebral haemorrhage, dysrhythmias such as transient bradycardia followed by tachycardia that may result in arrhythmia, myocardial necrosis, acute pulmonary oedema, renal insufficiency)

The effects of adrenaline may be counteracted, depending on the condition of the patient, by administration of quick-acting vasodilators, of quick-acting alpha- adrenoreceptor blocking agents (e.g. phentolamine), or beta-adrenoreceptor blocking agents (e.g. propranolol). However, due to the short half-life of adrenaline, treatment with these medicines may not be necessary. In case of prolonged hypotensive reaction, administration of another vasopressive agent such as noradrenaline may be required.

🇷🇴 Known in Romania as

Medicines sold in Romania with the same active substance: Cunoscut în România ca

⚠ Not the same combination. This medicine contains Adrenaline acid tartrate. The products below do not contain exactly the same set of active substances — they are not direct substitutes.

  • SEPTANEST CU ADRENALINA 1/100000 prescription partial — not the same combinationCOMBINATII (ARTICAINUM+ADRENALINUM) · injection / infusion
  • SEPTANEST CU ADRENALINA 1/200000 prescription partial — not the same combinationCOMBINATII (ARTICAINUM+ADRENALINUM) · injection / infusion
  • ARTIDENTAL 40 mg/0,005 mg/ml prescription partial — not the same combinationCOMBINATII (ARTICAINUM+ADRENALINUM) · injection / infusion
  • ARTIDENTAL 40 mg/0,01 mg/ml prescription partial — not the same combinationCOMBINATII (ARTICAINUM+ADRENALINUM) · injection / infusion
  • NORMOCAIN 40 mg/0,005 mg/ml prescription partial — not the same combinationCOMBINATII (ARTICAINUM+ADRENALINUM) · injection / infusion
  • NORMOCAIN 40 mg/0,010 mg/ml prescription partial — not the same combinationCOMBINATII (ARTICAINUM+ADRENALINUM) · injection / infusion

Some of these do not contain exactly the same active substances — check each one. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Romanian medicines in the UK →

🇵🇱 Known in Poland as

Medicines sold in Poland with the same active substance: W Polsce znany jako

  • Adrenalina WZF 0,1%Adrenalinum · injection / infusion
  • Adrenalina WZFAdrenalinum · injection / infusion
  • Adrenalina AguettantAdrenalinum · injection / infusion
  • JextAdrenalinum · injection / infusion
  • Adrenalina NoridemAdrenalinum · injection / infusion

Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →

💬 Ask about this leaflet

Ask anything about Adrenaline (Epinephrine) 1mg/ml (1:1000) solution for injection (ampoule). The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.

Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.

Pharmacies in major towns and cities — see the list
Pharmacies by county and region — see the full list

Browse all 2,009 towns and cities →